The SORTIE trial: palliation with stent (S) or radiation therapy (RT) 20 Gy in 5 fractions intervention for esophageal cancer dysphagia: a multicenter trial for T-4, M+/- squamous or adenocarcinoma of the esophagus. a randomized trial relief from dysphagia and quality of life (QOL) analysis

A.T Turrisi,R.H Hawes,Y Palesch,C Redmond,T Williams,C Reed,P Mauldin,P.B Cotton

doi:10.1016/s0360-3016(02)03284-4

The SORTIE trial: palliation with stent (S) or radiation therapy (RT) 20 Gy in 5 fractions intervention for esophageal cancer dysphagia: a multicenter trial for T-4, M+/- squamous or adenocarcinoma of the esophagus. a randomized trial relief from dysphagia and quality of life (QOL) analysis

A.T Turrisi, R.H Hawes + Show 6 more

Open Access

https://doi.org/10.1016/s0360-3016(02)03284-4

Copy DOI

Journal: International Journal of Radiation Oncology, Biology, Physics	Publication Date: Sep 20, 2002
Citations: 6

Affiliation: Medical University of South Carolina, University of Pittsburgh

#External Beam Radiotherapy For Palliation #Non-resectable Esophageal Cancer + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Purpose/Objective: SORTIE, multicenter, randomized trial tests Ultraflex® ∗stent versus high fraction external beam radiotherapy for palliation of dysphagia for patients with locally advanced, non-resectable esophageal cancer. A secondary goal compared Quality of Life.

Full Text